Susquehanna Advisors Group’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
73,870
-7,824
-10% -$122K 0.02% 86
2026
Q1
$1.03M Sell
81,694
-858
-1% -$8.7K 0.03% 84
2025
Q4
$717K Hold
82,552
0.01% 115
2025
Q3
$774K Sell
82,552
-9,560
-10% -$89.1K 0.01% 108
2025
Q2
$826K Sell
92,112
-5,536
-6% -$44.2K 0.02% 84
2025
Q1
$851K Hold
97,648
0.03% 52
2024
Q4
$813K Buy
+97,648
New +$721K 0.02% 104

Other funds holding ADTN

Susquehanna Advisors Group's ADTN Position: Q2 2026 in Review

Susquehanna Advisors Group reduced its Adtran (ADTN) stake by 9.6% in Q2 2026, selling an estimated $122K and leaving 73,870 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #86.

Susquehanna Advisors Group first reported a position in ADTN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.03M in Q1 2026. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Susquehanna Advisors Group held 73,870 shares of Adtran worth $1.03M as of Q2 2026.
  • Susquehanna Advisors Group sold 7,824 Adtran shares in Q2 2026, an estimated $122K.
  • Adtran made up 0.02% of Susquehanna Advisors Group's portfolio in Q2 2026, its #86 holding.
  • Susquehanna Advisors Group first reported a position in Adtran in Q4 2024 and has held it in 7 quarters since.
  • Susquehanna Advisors Group's Adtran position peaked at $1.03M in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Susquehanna Advisors Group's 13F filing for Q2 2026, filed 14 Aug 2026.